Since the 1980s, the number of new drug products coming through the drug discovery and development pipeline has started decreasing. Data suggest that out of 10000 drug compounds entering the initial drug discovery phase, less than one drug finds its way to the patient population. Experts hypothesize that all easily developed drugs are now exhausted, […]